Generic pipeline of products is yet again a smart...

  1. 567 Posts.
    lightbulb Created with Sketch. 460
    Generic pipeline of products is yet again a smart strategy.
    Allows revenue regardless of how large to trickle in providing effective cash flow that can be used to streamline patented products they are wanting to get through the FDA process.

    This is one major win for the 3 year plan with this equity.

    Very very interesting to see where this stock ends up in the next 12-24 months
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $13.72K 687.1K

Buyers (Bids)

No. Vol. Price($)
6 618035 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 10000 1
View Market Depth
Last trade - 14.19pm 18/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.